Type 2 segmental manifestation of cutaneous leiomyomatosis in four unrelated women with additional uterine leiomyomas (Reed's syndrome) [3]

Dermatology

Volumn 212, Issue 1, 2005, Pages 84-87

  Ritzmann, Sibylle ^a   Hanneken, Sandra ^a   Neumann, Norbert J ^a   Ruzicka, Thomas ^a   Kruse, Roland ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Hereditary leiomyomatosis with renal cell cancer; Leiomyoma; Reed's syndrome; Segmental cutaneous leiomyomatosis

Indexed keywords

BOTULINUM TOXIN; CAPSAICIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; GABAPENTIN; GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; MIRTAZAPINE; OXYCODONE; POLIDOCANOL;

ADULT; CASE REPORT; CLINICAL EXAMINATION; FAMILY HISTORY; FEMALE; HISTOLOGY; HUMAN; HYSTERECTOMY; LASER SURGERY; LEIOMYOMA; LETTER; LOW LEVEL LASER THERAPY; PAIN; PRIORITY JOURNAL; SKIN DEFECT; SKIN NODULE; TRICHILEMMOMA; TUMOR VOLUME; UTERUS MYOMA;

ADULT; FEMALE; HUMANS; LEIOMYOMA; LEIOMYOMATOSIS; MIDDLE AGED; SKIN NEOPLASMS; SYNDROME; UTERINE NEOPLASMS;

EID: 28844473140     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089031     Document Type: Letter

References (18)

1. Jolliffe DS: Multiple cutaneous leiomyomata. Clin Exp Dermatol 1978;3:389-392.
2. Holst VA, Junkins-Hopkins JM, Elenitas R: Cutaneous smooth muscle neoplasms: Clinical features, histologic findings, and treatment options. J Am Acad Dermatol 2002;46:477-490.
3. Reed WB, Walker R, Horowitz R: Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 1973;53:409-416.
4. Alam NA, Bevan S, Churchman M, Barclay E, Barker K, Jaeger EE, Nelson HM, Healy E, Pembroke AC, Friedmann PS, Dalziel K, Calonje E, Anderson J, August PJ, Davies MG, Felix R, Munro CS, Murdoch M, Rendall J, Kennedy S, Leigh IM, Kelsell DP, Tomlinson IP, Houlston RS: Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome Iq42.3-q43. Am J Hum Genet 2001;68:1264-1269.
5. Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D, Leigh I, Gorman P, Lamlum H, Rahman S, Roylance RR, Olpin S, Bevan S, Barker K, Hearle N, Houlston RS, Kiuru M, Lehtonen R, Karhu A, Vilkki S, Laiho P, Eklund C, Vierimaa O, Aittomaki K, Hietala M, Sistonen P, Paetau A, Salovaara R, Herva R, Launonen V, Aaltonen LA; Multiple Leiomyoma Consortium: Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-410.
6. Kiuru M, Lehtonen R, Arola J, Salovaara R, Jarvinen H, Aittomaki K, Sjoberg J, Visakorpi T, Knuutila S, Isola J, Delahunt B, Herva R, Launonen V, Karhu A, Aaltonen LA: Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res 2002;62:4554-4557.
7. Martinez-Mir A, Glaser B, Chuang GS, Horev L, Waldman A, Engler DE, Gordon D, Spelman LJ, Hatzibougias I, Green J, Christiano AM, Zlotogorski A: Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata. J Invest Dermatol 2003;121:741-744.
8. Launonen V, Vierimaa O, Kiuru M, Isola J, Roth S, Pukkula E, Sistonen P, Herva R, Aaltonen LA: Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA 2001;98:3387-3392.
9. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, Barclay E, Calonje E, Manek S, Adams SJ, Bowers PW, Burrows NP, Charles-Holmes R, Cook LJ, Daly BM, Ford GP, Fuller LC, Hadfield-Jones SE, Hardwick N, Highet AS, Keefe M, McDonald-Hull SP, Potts ED, Crone M, Wilkinson S, Camacho-Martinez F, Jablonska S, Ratnavel R, MacDonald A, Mann RJ, Grice K, Guillet G, Lewis-Jones MS, McGrath H, Seukeran DC, Morrison PJ, Fleming S, Rahman S, Kelsell D, Leigh I, Olpin S, Tomlinson IP: Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 2003;12:1241-1252.
10. Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B: Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003;73:95-106.
11. Lang K, Reifenberger J, Ruzicka T, Megahed M: Type 1 segmental cutaneous leiomyomatosis. Clin Exp Dermatol 2002;27:649-650.
12. Happle R: Segmental type 2 manifestation of autosomal dominant skin diseases. Development of a new formal genetic concept. Hautarzt 2001;52:283-287.
13. Happle R: A rule concerning the segmental manifestation of autosomal dominant skin disorders: Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997;133:1505-1509.
14. König A, Happle R: Two cases of type 2 segmental manifestation in a family with cutaneous leiomyomatosis. Eur J Dermatol 2000;10:590-592.
15. König A, Happle R: Type 2 segmental cutaneous leiomyomatosis. Acta Derm Venereol 2001;81:383.
16. Poblete-Gutiérrez P, Wiederholt T, König A, Jugert FK, Marquardt Y, Rübben A, Merk HF, Happle R, Frank J: Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest 2004;114:14467-1476.
17. Stewart EA: Uterine fibroids. Lancet 2001;357:293-298.
18. Garman ME, Blumberg MA, Ernst R, Raimer SS: Familial leiomyomatosis: A review and discussion of pathogenesis. Dermatology 2003;207:210-213.